Tetratherix Ltd

NEW
ASX:TTX (Australia)  
A$ 7.13 +0.055 (+0.78%) Sep 7
At Loss
P/B:
11.55
Market Cap:
A$ 375.12M ($ 270.73M)
Enterprise V:
A$ 351.73M ($ 253.84M)
Volume:
34.94K
Avg Vol (2M):
26.29K
Trade In:
Volume:
34.94K
At Loss
Avg Vol (2M):
26.29K

Business Description

Description
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications, including Bone Regeneration, Tissue Spacing and Tissue Healing.
Name Current Vs Industry Vs History
Cash-To-Debt
3.13
Equity-to-Asset
0.62
Debt-to-Equity
0.34
Debt-to-EBITDA
-1.32
Piotroski F-Score
N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
10.35
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
-29.2
3-Year EPS without NRI Growth Rate
-32.6
3-Year FCF Growth Rate
-45.2
Future 3-5Y Total Revenue Growth Rate Estimate
105.59

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
65.64
9-Day RSI
59.59
14-Day RSI
56.34
3-1 Month Momentum %
30.51
6-1 Month Momentum %
98.45
12-1 Month Momentum %
99.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.5
Quick Ratio
4.47
Cash Ratio
4.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-1.8
Shareholder Yield %
-5.95
Name Current Vs Industry Vs History
Operating Margin %
-1361.33
Net Margin %
-1015.36
EBITDA Margin %
-903.59
FCF Margin %
-863.83
OCF Margin %
-258.82
ROE %
-33.15
ROA %
-22.72
ROIC %
-97.34
ROC (Joel Greenblatt) %
-102.12
ROCE %
-25.16

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
395.84
PB Ratio
11.55
Price-to-Tangible-Book
11.88
EV-to-EBIT
-38.14
EV-to-EBITDA
-42.4
EV-to-Revenue
383.14
EV-to-FCF
-44.35
Price-to-Net-Current-Asset-Value 21.59
Price-to-Net-Cash 27.4
Earnings Yield (Greenblatt) %
-2.62
FCF Yield %
-2.11

Financials

ASX:TTX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Tetratherix Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.918
EPS (TTM) (A$) -0.184
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 68.84
14-Day RSI 56.34
14-Day ATR (A$) 0.416312
20-Day SMA (A$) 6.67575
12-1 Month Momentum % 99.48
52-Week Range (A$) 3.09 - 8.08
Shares Outstanding (Mil) 53.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tetratherix Ltd Filings

Filing Date Document Date Form
No Filing Data

Tetratherix Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Tetratherix Ltd Frequently Asked Questions

What is Tetratherix Ltd(ASX:TTX)'s stock price today?
The current price of ASX:TTX is A$7.13. The 52 week high of ASX:TTX is A$8.08 and 52 week low is A$3.09.
When is next earnings date of Tetratherix Ltd(ASX:TTX)?
The next earnings date of Tetratherix Ltd(ASX:TTX) is .
Does Tetratherix Ltd(ASX:TTX) pay dividends? If so, how much?
Tetratherix Ltd(ASX:TTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Tetratherix Ltd

No articles.